首页> 外文OA文献 >Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1

【2h】

Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1

机译：评估基于双特异性抗体的抑制剂对人和小鼠凝血酶可激活的纤维蛋白溶解抑制剂和纤溶酶原激活物抑制剂-1的纤溶作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

status: published

机译：状态：已发布

著录项

作者
Wyseure, Tine; Gils, Ann; Declerck, Paul;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 [J] . WyseureT., GilsA., DeclerckP.J. Journal of thrombosis and haemostasis: JTH . 2013,第11期

机译：评估基于双特异性抗体的抑制剂对人和小鼠凝血酶可激活的纤维蛋白溶解抑制剂和纤溶酶原激活物抑制剂-1的纤溶作用
2. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. [J] . Erem C, Nuhoglu I, Yilmaz M Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology . 2009,第2期

机译：库欣综合症患者的凝血和纤溶作用：纤溶酶原激活物抑制剂1增加，组织因子途径抑制剂减少，凝血酶可激活的纤溶抑制剂水平不变。
3. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. [J] . Erem C, Nuhoglu I, Yilmaz M Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology . 2009,第2Suppla期

机译：库欣综合症患者的凝血和纤溶作用：纤溶酶原激活物抑制剂1增加，组织因子途径抑制剂减少，凝血酶可激活的纤溶抑制剂水平不变。
4. Lack of association of 4G/5G polymorphism in plasminogen activator inhibitor-1 gene with stroke [C] . Masaru Shoji, Shoji Tsutaya, Chiyako Oshikata, Hirosaki International Forum of Medical Science . 2003

机译：血液原激活剂抑制剂-1基因中缺乏4g / 5g多态性的关联卒中
5. Modeling of fibrinolysis and thrombin-activatable fibrinolysis inhibitor. [D] . Butler, Michael Jeffery. 2002

机译：纤维蛋白溶解和凝血酶激活的纤维蛋白溶解抑制剂的建模。
6. Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor [O] . Yusuke Ito, Kengo Noguchi, Yoshiyuki Morishima, -1

机译：组织型纤溶酶原激活物转基因大鼠用于评估凝血酶可激活的纤溶抑制剂的激活形式的抑制剂
7. Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients [O] . I. FERNANDEZ-CADENAS, J. ALVAREZ-SABIN, M. RIBO, 2007

机译：凝血酶活性纤维蛋白溶解抑制剂和纤溶酶原激活素抑制剂-1基因多态性对缺血性卒中患者组织型纤溶酶原激活剂诱导的再生的影响

Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅